Alzamend Neuro, Inc. Recorded Big Gain
Thu, May 29, 2025 at 07:28 PM
Alzamend Neuro, Inc. (ALZN:NASDAQ) rocketted at $5.44, a gain of 63.9%. On Thu, May 29, 2025, ALZN:NASDAQ hit a New 2-Week High of $5.44. The stock got featured on our News Catalysts scanner on Thu, May 29, 2025 at 09:40 AM in the 'BIOTECH' category. From Thu, May 15, 2025, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Thu, May 29, 2025 at $8.22 with a volume of 77M+.
About Alzamend Neuro, Inc. (ALZN:NASDAQ)
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders.
Top 10 Gainers:
- SharpLink Gaming, Inc. (SBET:NASDAQ), 171.64%
- Harvard Bioscience, Inc. (HBIO:NASDAQ), 135.74%
- Streamline Health Solutions, Inc. (STRM:NASDAQ), 133.33%
- Zeo Energy Corp. (ZEO:NASDAQ), 121.29%
- Webus International Limited (WETO:NASDAQ), 88.07%
- IM Cannabis Corp. (IMCC:NASDAQ), 78.85%
- Alzamend Neuro, Inc. (ALZN:NASDAQ), 63.86%
- LZ Technology Holdings Limited (LZMH:NASDAQ), 47%
- ModivCare Inc. (MODV:NASDAQ), 46.58%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 41.41%